{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:38:25Z","timestamp":1769125105841,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T00:00:00Z","timestamp":1322265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10557-011-6348-y","type":"journal-article","created":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T04:48:13Z","timestamp":1322196493000},"page":"47-56","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and Safety of Tolvaptan in Heart Failure Patients with Sustained Volume Overload despite the Use of Conventional Diuretics: A Phase III Open-Label Study"],"prefix":"10.1007","volume":"25","author":[{"name":"for the Tolvaptan Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatake","family":"Fukunami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masunori","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,26]]},"reference":[{"key":"6348_CR1","unstructured":"Japanese Circulation Society. Guidelines for the diagnosis and treatment of cardiovascular disease (Joint Study Group Report 2009): guidelines for treatment of chronic heart failure (revised 2010). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2010_matsuzaki_h.pdf . Accessed 13 April 2011."},{"key":"6348_CR2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","volume":"41","author":"A Nohria","year":"2003","unstructured":"Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41:1797\u2013804.","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"6348_CR3","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1136\/hrt.72.2_Suppl.S44","volume":"72","author":"EB Raftery","year":"1994","unstructured":"Raftery EB. Haemodynamic effects of diuretics in heart failure. Br Heart J. 1994;72(suppl):S44\u20137.","journal-title":"Br Heart J"},{"issue":"Suppl G","key":"6348_CR4","doi-asserted-by":"crossref","first-page":"G8","DOI":"10.1016\/S0195-668X(01)80003-8","volume":"3","author":"I Anand","year":"2001","unstructured":"Anand I, Florea VG. Diuretics in chronic heart failure\u2014benefits and hazards. Eur Heart J Suppl. 2001;3(Suppl G):G8\u2013G18.","journal-title":"Eur Heart J Suppl"},{"key":"6348_CR5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/eurheartj\/ehi176","volume":"26","author":"S Gupta","year":"2005","unstructured":"Gupta S, Neyses L. Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J. 2005;26:644\u20139.","journal-title":"Eur Heart J"},{"key":"6348_CR6","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"SA Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin MH, et al. ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154\u2013235.","journal-title":"Circulation"},{"key":"6348_CR7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","volume":"287","author":"Y Yamamura","year":"1998","unstructured":"Yamamura Y, Nakamura S, Itoh S, et al. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther. 1998;287:860\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"6348_CR8","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Niazi I, Ouyang J, et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation. 2003;107:2690\u20136.","journal-title":"Circulation"},{"key":"6348_CR9","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","volume":"290","author":"LC Costello-Boerrigter","year":"2006","unstructured":"Costello-Boerrigter LC, Smith WB, Boerrigter G, et al. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Renal Physiol. 2006;290:F273\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"6348_CR10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00535-010-0240-6","volume":"45","author":"K Okita","year":"2010","unstructured":"Okita K, Sakaida I, Okada M, et al. A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose\u2013response of tolvaptan in patients with decompensated liver cirrhosis. J Gastroenterol. 2010;45:979\u201387.","journal-title":"J Gastroenterol"},{"key":"6348_CR11","doi-asserted-by":"crossref","unstructured":"Matsuzaki M, Masatsugu H, Izumi T, Asanoi H, Tsutamoto T, Tolvaptan Investigators. Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Cardiovasc Drugs Ther. 2011; e-pub ahead of print.","DOI":"10.1007\/s10557-011-6303-y"},{"key":"6348_CR12","doi-asserted-by":"crossref","unstructured":"Matsuzaki M, Fukunami M, Hori M, Izumi T, Tolvaptan Investigators. Efficacy and safety of tolvaptan in heart failure patients with excessive fluid retention following treatment with other diuretics: a phase iii, randomized, double-blinded and placebo-controlled study (The QUEST study). Cardiovasc Drugs Ther. 2011; e-pub ahead of print.","DOI":"10.1007\/s10557-011-6304-x"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-011-6348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-011-6348-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-011-6348-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T13:18:31Z","timestamp":1741958311000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-011-6348-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,26]]},"references-count":12,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["6348"],"URL":"https:\/\/doi.org\/10.1007\/s10557-011-6348-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,26]]}}}